Elevance Health (ELV) Change in Accured Expenses (2010 - 2026)

Elevance Health (ELV) has 17 years of Change in Accured Expenses data on file, last reported at $2.9 billion in Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $2.9 billion, up 203.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 29.56% YoY), and the FY2025 annual result was -$720.0 million, down 164.71% from the prior year.
• Change in Accured Expenses advanced to $2.9 billion in Q1 2026 per ELV's latest filing, from -$2.3 billion in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $2.9 billion in Q1 2026 and troughed at -$2.3 billion in Q4 2025.
• A 5-year average of $256.4 million and a median of $204.0 million in 2022 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses surged 4679.41% in 2023, then slumped 1527.78% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at $226.0 million in 2022, then tumbled by 134.07% to -$77.0 million in 2023, then tumbled by 1458.44% to -$1.2 billion in 2024, then tumbled by 88.25% to -$2.3 billion in 2025, then jumped by 227.76% to $2.9 billion in 2026.
• Business Quant data shows ELV's Change in Accured Expenses at $2.9 billion in Q1 2026, -$2.3 billion in Q4 2025, and -$151.0 million in Q3 2025.